Generation of polyclonal antibody with high avidity to rosuvastatin and its use in development of highly sensitive ELISA for determination of rosuvastatin in plasma-Reference-Cited by-同舟云学术

Generation of polyclonal antibody with high avidity to rosuvastatin and its use in development of highly sensitive ELISA for determination of rosuvastatin in plasma

Published:2011-07-05 Issue:1 Volume:5 Page:
ISSN:1752-153X
Container-title:Chemistry Central Journal
language:en
Short-container-title:Chemistry Central Journal

Author:

Darwish Ibrahim A,Al-Obaid Abdul-Rahman M,Al-Malaq Hamoud A

Publisher

Springer Science and Business Media LLC

Subject

General Chemistry

Link

http://link.springer.com/content/pdf/10.1186/1752-153X-5-38.pdf

Reference23 articles.

1. Antonopoulos S, Mikros S, Mylonopoulou M, Kokkoris S, Giannoulis G: Rosuvastatin as a novel treatment of non-alcoholic fatty liver disease in hyperlipidemic patients. Atherosclerosis. 2006, 184: 233-234. 10.1016/j.atherosclerosis.2005.08.021.

2. Cooper KJ, Martin PD, Dane AL, Warwick MJ, Raza A, Schneck DW: Lack of effect of ketoconazole on the pharmacokinetics of rosuvastatin in healthy subjects. Br J Clin Pharmacol. 2003, 55: 94-99. 10.1046/j.1365-2125.2003.01720.x.

3. Lan K, Jiang X, Li Y, Wang L, Zhou J, Jiang Q, Ye L: Quantitative determination of rosuvastatin in human plasma by ion pair liquid-liquid extraction using liquid chromatography with electrospray ionization tandem mass spectrometry. J Pharm Biomed Anal. 2007, 44: 540-546. 10.1016/j.jpba.2006.12.022.

4. Dong-Hang X, Zou-Rong R, Quan Z, Hong Y, Bo J: Quantitative determination of rosuvastatin in human plasma by liquid chromatography with electrospray ionization tandem mass spectrometry. Rapid Commun Mass Spectrom. 2006, 20: 2369-2375. 10.1002/rcm.2542.

5. Gao J, Zhong D, Duan X, Chen XJ: Liquid chromatography/negative ion electrospray tandem mass spectrometry method for the quantification of rosuvastatin in human plasma: Application to a pharmacokinetic study. Chromatogr B Biomed Sci Appl. 2007, 856: 35-40. 10.1016/j.jchromb.2007.05.012.

Cited by 6 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Quantitative Analysis in PET Imaging;Basic Sciences of Nuclear Medicine;2021

2. Development of two different formats of heterogeneous fluorescence immunoassay for bioanalysis of afatinib by employing fluorescence plate reader and KinExA 3200 immunosensor;Scientific Reports;2019-10-14

3. Development and comparative evaluation of two immunoassay platforms for bioanalysis of crizotinib: A potent drug used for the treatment of non-small cell lung cancer;Talanta;2019-08

4. Synthesis of hapten, generation of specific polyclonal antibody and development of ELISA with high sensitivity for therapeutic monitoring of crizotinib;PLOS ONE;2019-02-11

5. Development and validation of an ELISA with high sensitivity for therapeutic monitoring of afatinib;Bioanalysis;2018-09-01